Pfizer sought CHMP Opinion for MYLOTARG and BOSULIF
Pfizer asserted that that the Committee for Medicinal products for Human use of the European Medicines Agency has adopted positive opinions extending marketing authorizations in the EU…
Read More...
Read More...
